Biological Significance of Dual Mutations A494D and E495K of the Genotype III Newcastle Disease Virus Hemagglutinin-Neuraminidase In Vitro and In Vivo
- PMID: 36366435
- PMCID: PMC9696791
- DOI: 10.3390/v14112338
Biological Significance of Dual Mutations A494D and E495K of the Genotype III Newcastle Disease Virus Hemagglutinin-Neuraminidase In Vitro and In Vivo
Abstract
As a multifunctional protein, the hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) is involved in various biological functions. A velogenic genotype III NDV JS/7/05/Ch evolving from the mesogenic vaccine strain Mukteswar showed major amino acid (aa) mutations in the HN protein. However, the precise biological significance of the mutant HN protein remains unclear. This study sought to investigate the effects of the mutant HN protein on biological activities in vitro and in vivo. The mutant HN protein (JS/7/05/Ch-type HN) significantly enhanced the hemadsorption (HAd) and fusion promotion activities but impaired the neuraminidase (NA) activity compared with the original HN protein (Mukteswar-type HN). Notably, A494D and E495K in HN exhibited a synergistic role in regulating biological activities. Moreover, the mutant HN protein, especially A494D and E495K in HN, enhanced the F protein cleavage level, which can contribute to the activation of the F protein. In vitro infection assays further showed that NDVs bearing A494D and E495K in HN markedly impaired the cell viability. Simultaneously, A494D and E495K in HN enhanced virus replication levels at the early stage of infection but weakened later in infection, which might be associated with the attenuated NA activity and cell viability. Furthermore, the animal experiments showed that A494D and E495K in HN enhanced case fatality rates, virus shedding, virus circulation, and histopathological damages in NDV-infected chickens. Overall, these findings highlight the importance of crucial aa mutations in HN in regulating biological activities of NDV and expand the understanding of the enhanced pathogenicity of the genotype III NDV.
Keywords: Newcastle disease virus; biological significance; genotype III; hemagglutinin-neuraminidase protein; vaccine strain.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Amino Acid Mutations in Hemagglutinin-Neuraminidase Enhance the Virulence and Pathogenicity of the Genotype III Newcastle Disease Vaccine Strain After Intravenous Inoculation.Front Vet Sci. 2022 May 27;9:890657. doi: 10.3389/fvets.2022.890657. eCollection 2022. Front Vet Sci. 2022. PMID: 35711809 Free PMC article.
-
The haemagglutinin-neuraminidase protein of velogenic Newcastle disease virus enhances viral infection through NF-κB-mediated programmed cell death.Vet Res. 2024 May 7;55(1):58. doi: 10.1186/s13567-024-01312-y. Vet Res. 2024. PMID: 38715081 Free PMC article.
-
Increase in the neuraminidase activity of a nonpathogenic Newcastle disease virus isolate during passaging in chickens.J Vet Med Sci. 2010 Apr;72(4):453-7. doi: 10.1292/jvms.09-0474. Epub 2009 Dec 15. J Vet Med Sci. 2010. PMID: 20009427
-
Antigenic variation in hemagglutinin-neuraminidase of Newcastle disease virus isolated from Tibet, China.Vet Microbiol. 2023 Oct;285:109872. doi: 10.1016/j.vetmic.2023.109872. Epub 2023 Sep 8. Vet Microbiol. 2023. PMID: 37690146
-
Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells In Vitro: Contribution of the Cleavage Site of Fusion Protein and Second Sialic Acid Binding Site of Hemagglutinin-Neuraminidase.J Virol. 2017 Jul 27;91(16):e00770-17. doi: 10.1128/JVI.00770-17. Print 2017 Aug 15. J Virol. 2017. PMID: 28592535 Free PMC article.
Cited by
-
Cellular vimentin regulates the infectivity of Newcastle disease virus through targeting of the HN protein.Vet Res. 2023 Oct 17;54(1):92. doi: 10.1186/s13567-023-01230-5. Vet Res. 2023. PMID: 37848995 Free PMC article.
-
Changes in the Transcriptome Profile in Young Chickens after Infection with LaSota Newcastle Disease Virus.Vaccines (Basel). 2024 May 30;12(6):592. doi: 10.3390/vaccines12060592. Vaccines (Basel). 2024. PMID: 38932321 Free PMC article.
References
-
- Snoeck C.J., Owoade A.A., Couacy-Hymann E., Alkali B.R., Okwen M.P., Adeyanju A.T., Komoyo G.F., Nakoune E., Le Faou A., Muller C.P. High genetic diversity of Newcastle disease virus in poultry in West and Central Africa: Cocirculation of genotype XIV and newly defined genotypes XVII and XVIII. J. Clin. Microbiol. 2013;51:2250–2260. doi: 10.1128/JCM.00684-13. - DOI - PMC - PubMed
-
- Dimitrov K.M., Abolnik C., Afonso C.L., Albina E., Bahl J., Berg M., Briand F.-X., Brown I.H., Choi K.-S., Chvala I., et al. Updated unified phylogenetic classification system and revised nomenclature for Newcastle disease virus. Infect. Genet. Evol. 2019;74:103917. doi: 10.1016/j.meegid.2019.103917. - DOI - PMC - PubMed
-
- Gotoh B., Ohnishi Y., Inocencio N.M., Esaki E., Nakayama K., Barr P.J., Thomas G., Nagai Y. Mammalian subtilisin-related proteinases in cleavage activation of the paramyxovirus fusion glycoprotein: Superiority of furin/PACE to PC2 or PC1/PC3. J. Virol. 1992;66:6391–6397. doi: 10.1128/jvi.66.11.6391-6397.1992. - DOI - PMC - PubMed
-
- Ji Y., Liu T., Jia Y., Liu B., Yu Q., Cui X., Guo F., Chang H., Zhu Q. Two single mutations in the fusion protein of Newcastle disease virus confer hemagglutinin-neuraminidase independent fusion promotion and attenuate the pathogenicity in chickens. Virology. 2017;509:146–151. doi: 10.1016/j.virol.2017.06.021. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials